Tara Bancroft
Stock Analyst at TD Cowen
(2.08)
# 2,977
Out of 5,132 analysts
10
Total ratings
62.5%
Success rate
3.97%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Tara Bancroft
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DAWN Day One Biopharmaceuticals | Initiates: Buy | $34 | $11.23 | +202.76% | 1 | Jan 13, 2026 | |
| OCUL Ocular Therapeutix | Maintains: Buy | $14 → $20 | $9.16 | +118.34% | 4 | Oct 30, 2025 | |
| LNTH Lantheus Holdings | Maintains: Buy | $95 → $80 | $67.28 | +18.91% | 1 | Sep 15, 2025 | |
| TGTX TG Therapeutics | Initiates: Buy | $50 | $28.82 | +73.49% | 1 | Oct 29, 2024 | |
| PTGX Protagonist Therapeutics | Initiates: Buy | $65 | $83.49 | -22.15% | 1 | Sep 24, 2024 | |
| GERN Geron | Initiates: Buy | $10 | $1.61 | +521.12% | 1 | Apr 29, 2024 | |
| BCYC Bicycle Therapeutics | Initiates: Outperform | n/a | $5.53 | - | 1 | Aug 31, 2022 |
Day One Biopharmaceuticals
Jan 13, 2026
Initiates: Buy
Price Target: $34
Current: $11.23
Upside: +202.76%
Ocular Therapeutix
Oct 30, 2025
Maintains: Buy
Price Target: $14 → $20
Current: $9.16
Upside: +118.34%
Lantheus Holdings
Sep 15, 2025
Maintains: Buy
Price Target: $95 → $80
Current: $67.28
Upside: +18.91%
TG Therapeutics
Oct 29, 2024
Initiates: Buy
Price Target: $50
Current: $28.82
Upside: +73.49%
Protagonist Therapeutics
Sep 24, 2024
Initiates: Buy
Price Target: $65
Current: $83.49
Upside: -22.15%
Geron
Apr 29, 2024
Initiates: Buy
Price Target: $10
Current: $1.61
Upside: +521.12%
Bicycle Therapeutics
Aug 31, 2022
Initiates: Outperform
Price Target: n/a
Current: $5.53
Upside: -